Their therapeutic effects can be significantly improved through their combination with FAK inhibitors, which results in enhanced cell death and decreased tumor growth due to the inhibition of major signaling pathways, such as AKT phosphorylation [33]. This evidence concerns the gene AKT1 and neoplasm.